The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC)-Reference-Cited by-同舟云学术

The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC)

Published:2011-10 Issue:1 Volume:123 Page:129-137
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Dutta Sonia,Wang Feng-qiang,Wu Hai-shan,Mukherjee Thayer J.,Fishman David A.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference58 articles.

1. Cancer Statistics, 2010;Jemal;CA Cancer J Clin,2010

2. The follow-up of ovarian cancer;Vaidya;Semin Oncol,2003

3. A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer;du Bois;J Natl Cancer Inst,2003

4. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells;Fishman;Cancer Res,2001

5. Translocation of Fas by LPA prevents ovarian cancer cells from anti-Fas-induced apoptosis;Meng;Gynecol Oncol,2005

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lysophosphatidic acid promotes ESCC progression by increasing the level of CCL2 secreted by esophageal epithelial cells;The Journal of Gene Medicine;2024-06

2. Involvement of Aberrant DNA Methylation in the Deregulated Expression of EHF, LPAR1, MPZL3, and POPDC2 Genes in Equine Sarcoids;Annals of Animal Science;2024-01-01

3. Inhibition of LPA-LPAR1 and VEGF-VEGFR2 Signaling in IPF Treatment;Drug Design, Development and Therapy;2023-09

4. Neo-vascularization-based therapeutic perspectives in advanced ovarian cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-05

5. Efficacy of epi-1 modified epirubicin and curcumin encapsulated liposomes targeting-EpCAM in the inhibition of epithelial ovarian cancer cells;Journal of Liposome Research;2022-12-12